Clinical Study Provides Evidence for the Use of Arla Foods Ingredients' Lacprodan® IF-3070 in Infant Formula

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

AFI AFI COPENHAGEN, Denmark, March 22, 2026 (GLOBE NEWSWIRE) -- A clinical study published in Nutrients has shown that infant formula containing Arla Foods Ingredients’...

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients' Lacprodan® IF-3070 in Infant Formula

COPENHAGEN, Denmark, March 22, 2026 (GLOBE NEWSWIRE) -- A clinical study published in Nutrients has shown that infant formula containing Arla Foods Ingredients' Lacprodan® IF-3070 was well tolerated in infants, with growth and development indicators remaining within an appropriate range.1 The findings provide scientific evidence for formula development in early life nutrition. Lacprodan® IF-3070 is a partially hydrolysed whey protein ingredient …

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula - Thailand Tribune

AFI COPENHAGEN, Denmark, March 22, 2026 (GLOBE NEWSWIRE) — A clinical study published in Nutrients has shown that infant formula containing Arla Foods Ingredients’ Lacprodan® IF-3070 was well tolerated in infants, with growth and development indicators remaining within an appropriate range.1 The findings provide scientific evidence for formula development in early life nutrition. Lacprodan® IF-3070 is a partially hydrolysed whey protein […] The …